Carlos Sanchez

Carlos Sanchez, M.D., is a board-eligible neurosurgeon specializing in Pediatric Neurosurgery, currently serving as Co-Founder of GlioQuell since June 2022. As a Principal Investigator at the GW Cancer Center and a Neuro-Oncology and Pediatric Neurosurgeon at The George Washington University Hospital, Carlos Sanchez contributes to cancer research and immunotherapy. Carlos Sanchez holds a faculty position as an Assistant Professor at The George Washington University and previously directed Skull Base Surgery at Children's National Hospital. Additional roles include consultant for the FDA's Cellular Tissue and Gene Therapies Advisory Committee and membership on the Board of Advisors at Columbia University Mailman School of Public Health. Carlos Sanchez's extensive training includes fellowships in Pediatric Neurosurgery and Neurocritical Care, and education from institutions such as SGU School of Medicine and Harvard University.